Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/2037971
King Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report
Description:
Synopsis
ICD Research's "King Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
Summary
ICD Research's "King Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" is a crucial resource for industry executives and anyone looking to access key information about King Pharmaceuticals, Inc..
ICD Research's "King Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about "King Pharmaceuticals, Inc." for business intelligence requirements.
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of "King Pharmaceuticals, Inc.".
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
Key Highlights
King Pharmaceuticals, Inc. (King) was an integrated pharmaceutical company focused on the development, manufacture and marketing of branded prescription pharmaceutical products and animal health products. It developed therapies and technologies to the markets including neuroscience, hospital and acute care medicines. Its branded prescription pharmaceuticals comprised neuroscience products, hospital products and legacy brands. Its animal health products included medicated feed additives (MFAs) and water-soluble therapeutics primarily for poultry, cattle, and swine. Its branded prescription pharmaceutical products were marketed to general/family practitioners, internal medicine physicians, neurologists, pain specialists, surgeons and hospitals across the United States and in Puerto Rico. The company's animal health products were marketed to veterinarians and nutritionists. The company's product line included Avinza, CII Skelaxin, Thrombin-JMI, Altace, Levoxyl, Cytomel, Sonata, CIV Meridian and Auto injector Products/EpiPen. The company was headquartered in Bristol, Tennessee, United States.
ICD Research's "King Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
Summary
ICD Research's "King Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" is a crucial resource for industry executives and anyone looking to access key information about King Pharmaceuticals, Inc..
ICD Research's "King Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about "King Pharmaceuticals, Inc." for business intelligence requirements.
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of "King Pharmaceuticals, Inc.".
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
Key Highlights
King Pharmaceuticals, Inc. (King) was an integrated pharmaceutical company focused on the development, manufacture and marketing of branded prescription pharmaceutical products and animal health products. It developed therapies and technologies to the markets including neuroscience, hospital and acute care medicines. Its branded prescription pharmaceuticals comprised neuroscience products, hospital products and legacy brands. Its animal health products included medicated feed additives (MFAs) and water-soluble therapeutics primarily for poultry, cattle, and swine. Its branded prescription pharmaceutical products were marketed to general/family practitioners, internal medicine physicians, neurologists, pain specialists, surgeons and hospitals across the United States and in Puerto Rico. The company's animal health products were marketed to veterinarians and nutritionists. The company's product line included Avinza, CII Skelaxin, Thrombin-JMI, Altace, Levoxyl, Cytomel, Sonata, CIV Meridian and Auto injector Products/EpiPen. The company was headquartered in Bristol, Tennessee, United States.
Contents:
1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Mergers & Acquisitions and Partnerships
2.1 M&A and Partnerships Strategy
3 recent developments
4 SWOT Analysis
4.1 SWOT Analysis - Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats
5 history
6 Key employees
7 locations and Subsidiaries
7.1 Head Office
7.2 Other locations and Subsidiaries
8 Appendix
8.1 Methodology
8.2 Disclaimer
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Mergers & Acquisitions and Partnerships
2.1 M&A and Partnerships Strategy
3 recent developments
4 SWOT Analysis
4.1 SWOT Analysis - Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats
5 history
6 Key employees
7 locations and Subsidiaries
7.1 Head Office
7.2 Other locations and Subsidiaries
8 Appendix
8.1 Methodology
8.2 Disclaimer
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1582661
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Wednesday, May 22, 2013
12:02:21 PM
12:02:21 PM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
King Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report
Web Address
http://www.researchandmarkets.com/reports/2037971
Office Code
OC8DIQSPMUQUQW
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price | Electronic (PDF) - Enterprisewide |
|
EURO€ 288.00 |
|---|---|---|
| Electronic (PDF) - Single User |
|
EURO€ 96.00 |
| Electronic (PDF) - Site License |
|
EURO€ 192.00 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Wednesday, May 22, 2013
12:02:21 PM
12:02:21 PM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp